おすすめの製品
product name
NCI-H322 Cell Line human, 95111734
由来生物
human lung (cervical node metastasis)
詳細
Human Caucasian bronchioalveolar carcinoma
成長モード
Adherent
核型
Not specified
形態
Not specified
製品
Not specified
受容体
Not specified
テクニック
cell culture | mammalian: suitable
関連疾患
metastasis
輸送温度
dry ice
保管温度
−196°C
細胞株の由来
Human Caucasian bronchioalveolar carcinoma
細胞株の説明
NCI-H322 was derived in 1981 from a primary bronchioalveolar carcinoma of the lung from a 52 year old male taken prior to treatment. Ultrastructural studies of this non-small cell carcinoma cell line demonstrated the presence of cytoplasmic structures characteristic of Clara cells. NCI-H322 do not express UDP-glucuronosyltransferase, but are reported to express glutathione-S-transferase and phenol sulfotransferase. Expression of protein and RNA of SP-A, the major surfactant-associated protein was detected. The cells produce tumours in athymic mice.
アプリケーション
NCI-H322 has been used to study the preclinical antitumor efficacy of BAY 1129980, which is an anti-C4.4A (Ly6/PLAUR domain-containing protein 3 precursor-LYPD3) antibody–drug conjugate for the treatment of non–small cell lung cancer.
Test system for evaluating cytotoxicity and genotoxicity of chemicals to human lung
培地
RPMI 1640 + 2mM Glutamine + 5-10% Foetal Bovine Serum (FBS).
継代と培養方法
Split sub-confluent cultures (70-80%) 1:3 to 1:6 i.e. seeding at 1-3x10,000 cells/cm2 using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37°C.
その他情報
Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)